Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
about
Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4)Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.Modulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431Chapter 2: Kill the bacteria...and also their messengers?The dual role of lipopolysaccharide as effector and target molecule.Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice.CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognitionMembrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through toll-like receptor 2.Structural Relationship of the Lipid A Acyl Groups to Activation of Murine Toll-Like Receptor 4 by Lipopolysaccharides from Pathogenic Strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa.Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS.The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated.Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analoguesToll-like receptor activation of human cells by synthetic triacylated lipid A-like moleculesCD11c/CD18, a transmembrane signaling receptor for lipopolysaccharideDetoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.Pattern recognition receptors in equine endotoxaemia and sepsis.Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide.Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist.Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells.Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction.The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist.Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures.Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.The 2-aminogluconate isomer of rhizobium sin-1 lipid A can antagonize TNF-alpha production induced by enteric LPS.A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway.Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length.Lipopolysaccharide dependent cellular activation.Geranylgeranylacetone ameliorates inflammatory response to lipopolysaccharide (LPS) in murine macrophages: inhibition of LPS binding to the cell surface.E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharideEvaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.Membrane expression of soluble endotoxin-binding proteins permits lipopolysaccharide signaling in Chinese hamster ovary fibroblasts independently of CD14.Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4.Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity.
P2860
Q24798199-D5D98EF1-2D98-4D17-9CD5-BE68FCC3F502Q30836915-8AFA04BD-4542-4107-83EB-FBEAF0F9BBFFQ33596606-84441A62-EB4F-459C-B6D8-AD0D4C4E897DQ33606001-2BFE5A6A-CE19-4028-A75A-D4C75097A57AQ33616742-FF1E5432-F501-4A9C-A56B-80FEE17FD427Q33737234-3C553AAA-2FA2-48EA-AA56-EBF4EF11BC7AQ33876756-E0555AAA-4482-4221-94D8-E620EAEBF3EEQ33897705-12FE9225-5AF8-46AA-B204-EFC2A1852100Q34006771-FCD9FAAF-E6BA-4A3E-8A73-B106BD61510DQ34504085-1AB22F05-E019-4C0D-B3AC-FD97912023C6Q35107961-A179DE62-69DD-412E-98D1-622AB7BB2265Q35431045-C3F7A299-F205-4867-9754-3B7768DC0A56Q35737359-F48D0B08-5F49-415C-B9CC-B5E24D3A01ADQ35956577-E08825F2-6FFB-4638-94B3-B757A94BD66CQ36364736-0DA0FC6D-A09A-44A0-8381-2739AA8B6E32Q36944888-CC90F1A4-F8D4-400C-AF3F-DE7B9EAFC656Q36964293-471BE7A4-8F04-43F4-845A-971BBE12B7FDQ37337410-C090A8D7-B99D-4D35-9D48-8BE99736B885Q38011228-9F43D4A4-8FD4-4A37-A33A-57C16A8624C0Q39096977-DC5EF56E-C862-45C9-959C-732BE19B2186Q39513148-F1BCA848-6332-4356-97CE-6DE6AAAB6295Q39559351-C2A02C62-87DC-4325-B8E9-26CDFF1BB072Q39821499-D9D183B9-3D0C-4767-8EF8-D3986C0EBDFAQ39822606-0DA56089-00A7-4F9C-B136-503C4C8E1B72Q39936881-783272F8-7D95-426B-B7CD-FDA420F6AD56Q40063419-81DE864A-022B-4D4C-9EE9-7C1E85C86316Q40147608-5753C1B1-C6C3-4D64-B81F-1A2C7E597BCCQ40152507-AEB03FFB-9B40-4439-9375-8B66BA7F49F5Q40156369-AABDD1A8-7FDB-4FD4-8F6F-F71E1164FC80Q40269153-EB431E55-7B44-457B-A73B-F12671547DC7Q40345866-8E0EF844-B833-4B56-B18D-5C94AF2E14FAQ40849109-2D4AC380-754D-4C06-8EA3-EC4F5B9952AFQ41332565-A5A4A822-9E0D-4789-BEFA-50C8BF4CD2C4Q41402192-B0B140E5-F2F2-45FA-A8C8-41C80AA196B8Q41844963-96972055-55EF-49EB-918F-DE9301F88A6BQ41888869-4FFFD98C-72AE-48CE-A93E-C1172F1140A2Q42929847-D7DABC7E-A28F-476F-9F6E-665717E987FCQ44410845-FD48FE20-09FC-4838-9845-78679CF09483Q44563480-F7F4765B-E4F0-47A3-B625-3034FFF83B98Q45227521-A3B47DF6-F52C-444C-B3DF-B188DABA27D2
P2860
Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@en
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@nl
type
label
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@en
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@nl
prefLabel
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@en
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@nl
P2093
P2860
P356
P1476
Lipid IVA inhibits synthesis a ...... in human whole blood ex vivo.
@en
P2093
P2860
P356
10.1084/JEM.172.1.77
P407
P577
1990-07-01T00:00:00Z